Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Zealand Pharma A/S ZLDPY

Healthcare Biotechnology
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:ZLDPY)

Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide

GlobeNewswire October 12, 2017

Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States

GlobeNewswire August 1, 2017

Zealand reports royalty revenue for the second quarter of 2017

GlobeNewswire July 31, 2017

Zealand initiates first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes

GlobeNewswire July 3, 2017

Zealand to regain control of elsiglutide

GlobeNewswire June 12, 2017

New analysis shows Soliqua® 100/33 lowered HbA1c by more than 2% in patients with screening levels greater than 9%

GlobeNewswire June 10, 2017

Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia

GlobeNewswire June 10, 2017

Zealand to present at two international healthcare investor conferences in June 2017

GlobeNewswire June 2, 2017

Positive Phase 2a results with microdoses of dasiglucagon support use in a dual-hormone artificial pancreas system

GlobeNewswire May 23, 2017
View More News ››

Opinion & Analysis (GREY:ZLDPY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:ZLDPY)

Zealand Pharma announces upsizing of previously announced eq

BREAKING NEWS: $ZLDPF Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK...
whytestocks - June 25, 2024

Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed P

Breaking News: $ZLDPF Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss | BenzingaDanish...
whytestocks - June 21, 2024

Zealand Pharma announces positive topline results from the P

Breaking News: $ZLDPF Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial...
whytestocks - June 20, 2024

Zealand Pharma announces that Boehringer Ingelheim's survodu

Just In: $ZLDPF Zealand Pharma announces that Boehringer Ingelheim's survodutide demonstrates breakthrough improvement in liver...
whytestocks - June 7, 2024

Zealand Pharma announces that Boehringer Ingelheim will pres

News; $ZLDPF Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in...
whytestocks - June 6, 2024

$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀

iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver...
Saaaa1 - May 6, 2021
View more Bullboard ››

Revive Therapeutics Ltd

Revive Therapeutics Ltd

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ...
View More »